155 results on '"Kasperts N"'
Search Results
2. Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer
3. Inter-observer agreement in GTV delineation of bone metastases on CT and impact of MR imaging: A multicenter study
4. OC-0372: Phase 2 RCT comparing conventional radiotherapy with SBRT in patients with bone metastases
5. Impact of body fat distribution and sarcopenia on the overall survival in patients with spinal metastases receiving radiotherapy treatment: a prospective cohort study
6. A national comparative effectiveness study to assess definitive chemoradiation regimens in proximal oesophageal squamous cell cancer
7. A review on re-irradiation for recurrent and second primary head and neck cancer
8. Dexamethasone for prevention of pain flare; results from a phase 3 trial in painful bone metastases
9. 'First in man' treatments with the MRI-linac provide clinical proof of the concept
10. EP-1627 Impact of body morphology on survival in patients with bone metastases: A prospective cohort study
11. EP-1629 Recalcification in lytic bone metastases of the spine after radiotherapy
12. Sparing the surgical area with stereotactic body radiotherapy for combined treatment of spinal metastases: a treatment planning study
13. Improvement of Target Definition for Laryngeal and Hypopharyngeal Cancer on Computed Tomography, Magnetic Resonance Imaging, and 18-FDG Positron Emission Tomography Validated by Histopathology
14. Impact of body fat distribution and sarcopenia on the overall survival in patients with spinal metastases receiving radiotherapy treatment: a prospective cohort study.
15. OC-0388: Dexamethasone for prevention of pain flare; results from a phase 3 trial in painful bone metastases
16. PO-0863: “First in Man” treatments with the MRI-linac provide clinical proof of the concept
17. EP-1710: Pre- versus post-operative radiotherapy: complications after combined therapy for spinal metastases
18. First patients treated with a 1.5 T MRI-Linac: clinical proof of concept of a high-precision, high-field MRI guided radiotherapy treatment
19. 761P - A national comparative effectiveness study to assess definitive chemoradiation regimens in proximal oesophageal squamous cell cancer
20. SUN-P081: Indicators for Prophylactic Percutaneous Endoscopic Gastrostomy Placement in Patients with Head and Neck Cancer Undergoing Chemoradiotherapy or Cetuximab-Radiotherapy: a Consensus Protocol
21. PO-0746: Inter-observer variation in GTV delineation of bone metastases: a multicenter study
22. EP-1402: Impact of SBRT on pain and local control for bone metastases: a systematic review and meta-analysis
23. EP-1390: Superior target delineation of renal cell carcinoma bone metastases on MRI vs CT
24. PO-0969: Accelerated fractionation should start early for laryngeal/ hypopharyngeal cancer
25. PO-150: Age ≥ 70 is not an adverse prognostic factor for accelerated radiotherapy in head and neck cancer
26. Stereotactic body radiotherapy followed by surgery for unstable spinal metastases: Technical feasibility and safety study according to the IDEAL stages 1 and 2a.
27. Improvement of Target Definition for Laryngeal and Hypopharyngeal Cancer on Computed Tomography, Magnetic Resonance Imaging, and 18-FDG Positron Emission Tomography Validated by Histopathology
28. Sparing the surgical area with stereotactic body radiotherapy for combined treatment of spinal metastases: a treatment planning study.
29. PV-0516: Guideline development for tumor delineation on MR-images for laryngeal and hypophargeal cancer
30. PV-0515: GTV delineation of laryngopharyngeal carcinoma on PET is more accurate than on CT and MRI
31. Validation Is Crucial in Head and Neck Translational Imaging Research
32. Margin Reduction Based on Comparison of Histopathology With Delineations on CT, MRI, and FDG-PET in Laryngeal and Hypopharyngeal Cancer
33. PD-0419: Overestimation of tumor volume of laryngeal/hypopharyngeal cancer on MRI in clinical radiotherapy practice
34. OC-0068: Comparison of GTV delineations on CT, MRI and FDG-PET of laryngeal and hypopharyngeal carcinoma with histopathology
35. PO-117: Overestimation of tumor volume of laryngeal/hypopharyngeal cancer on MRI in clinical radiotherapy practice
36. Reirradiation in head and neck cancer: the Amsterdam experience
37. A prospective study on postoperative reirradiation (report) for recurrent and second primary head and neck squamous cell carcinoma
38. Improved GTV Delineation of Laryngeal/Hypopharyngeal Carcinoma on MRI by the Use of Delineation Guidelines
39. Gross Tumor Volume of Laryngeal/Hypopharyngeal Cancer Delineated on MRI Is Doubled Compared to Pathology
40. OC-0554: FDG-PET semi-automatic segmentation methods for GTV delineation in laryngeal and hypopharyngeal cancer
41. OC-0550: Overestimation of gross tumor volume of laryngeal/hypopharyngeal cancer on MRI in clinical radiotherapy practice
42. PD-025: Adding MR-Images to CT-Based GTV Delineation in Laryngeal Carcinoma: Effect On Interobserver Agreement
43. PO-097: Margin for Clinical Target Volume (CTV) in Laryngeal and Hypopharyngeal Cancer: A Histological Study
44. PO-090: Smaller Margins Do Matter in Radiotherapy for Laryngeal Cancer
45. PD-0439 CTV MARGIN IN LARYNGEAL AND HYPOPHARYNGEAL CANCER: A HISTOLOGY STUDY
46. PD-0300 VALIDATION OF DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING FOR AUTOMATIC TUMOR DELINEATION IN LARYNGEAL CANCER
47. EP-1311 ADDING MRI TO CT BASED DELINEATION IN SUPRAGLOTTIC LARYNGEAL CARCINOMA: EFFECT ON INTER-OBSERVER VARIABILITY
48. Validation of Imaging with Pathology in Laryngeal Cancer: Accuracy of the Registration Methodology
49. Validation of Diffusion Weighted Magnetic Resonance Imaging for Automatic Tumor Delineation in Laryngeal Cancer
50. 8567 POSTER Laryngo-esophageal Dysfunction-free Survival 2 Years After Primary Accelerated Radiotherapy of Larynx/Hypopharynx Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.